Area of research
Epidemiology · Pathology and Forensic Medicine
Research interest
Research interests include Liver Disease Diagnosis and Treatment, Alcohol Consumption and Health Effects, Liver Disease and Transplantation, and Iron Metabolism and Disorders.
Phosphatidylserine-Dependent Clearance of Damaged Red Blood Cells by Liver Sinusoidal Endothelial Cells in Alcohol-Related Liver Disease.
Evidence for alcohol-mediated hemolysis and erythrophagocytosis
Evidence for alcohol-mediated hemolysis and erythrophagocytosis
Insulin-like Growth Factor-1 Reflects Liver Disease Stage and Improves Prediction of Liver-related Mortality
Pharmacological Modulation of Liver and Spleen Stiffness in a Cirrhotic Rat Model.
Agile scores in MASLD and ALD: External validation and their utility in clinical algorithms.
Alcohol-Associated Liver Disease Outcomes: Critical Mechanisms of Liver Injury Progression.
Direct Ingestion of Oxidized Red Blood Cells (Efferocytosis) by Hepatocytes.
Confounders of Serum Phosphatidylethanol: Role of Red Blood Cell Turnover and Cirrhosis.
Non-invasive diagnosis of alcohol-related steatohepatitis in patients ongoing alcohol withdrawal based on cytokeratin 18 and transient elastography.
Genetic variation in <i>TERT</i> modifies the risk of hepatocellular carcinoma in alcohol-related cirrhosis: results from a genome-wide case-control study
Clinical, histological and molecular profiling of different stages of alcohol-related liver disease
German Guidelines on Screening, Diagnosis, and Treatment of Alcohol Use Disorders: Update 2021
German Guidelines on Screening, Diagnosis, and Treatment of Alcohol Use Disorders: Update 2021
PNPLA3(I148M) Inhibits Lipolysis by Perilipin-5-Dependent Competition with ATGL
Colocalization analysis of pancreas eQTLs with risk loci from alcoholic and novel non-alcoholic chronic pancreatitis GWAS suggests potential disease causing mechanisms
PNPLA3(I148M) Inhibits Lipolysis by Perilipin-5-Dependent Competition with ATGL.
Behandlung von riskantem, schädlichem und abhängigem Alkoholgebrauch
Refining the Baveno VI elastography criteria for the definition of compensated advanced chronic liver disease.
A genetic risk score and diabetes predict development of alcohol-related cirrhosis in drinkers
Development and Validation of a Novel Scoring System for Noninvasive Nonalcoholic Steatohepatitis Detection in Bariatric Patients.
Genome‐wide Association Study and Meta‐analysis on Alcohol‐Associated Liver Cirrhosis Identifies Genetic Risk Factors
Obesity, Diabetes, Coffee, Tea, and Cannabis Use Alter Risk for Alcohol-Related Cirrhosis in 2 Large Cohorts of High-Risk Drinkers
Alcoholic-Hepatitis, Links to Brain and Microbiome: Mechanisms, Clinical and Experimental Research
Prospective Comparison of Transient Elastography Using Two Different Devices: Performance of FibroScan and FibroTouch.
Non-invasive diagnosis and biomarkers in alcohol-related liver disease
Genetic Variation in HSD17B13 Reduces the Risk of Developing Cirrhosis and Hepatocellular Carcinoma in Alcohol Misusers
Susceptibility based multiparametric quantification of liver disease: Non-invasive evaluation of steatosis and iron overload
Open-label Study with Nalmefene as Needed Use in Alcohol-Dependent Patients with Evidence of Elevated Liver Stiffness and/or Hepatic Steatosis
Fehlen des linken Leberlappens